23andMe’s stock tumbles 7% after independent directors quit in clash with CEO over buyout plan

The directors said the decision comes after months of work that failed to result in an actionable plan that meets the interests of non-affiliated shareholders.

Previous post Oil pulls back, with rise in crude inventories offsetting Middle East tensions
Next post Here’s when falling interest rates will hit your mortgage, car loan, credit-card bills and savings accounts